Esperion Therapeutics
Erin J McDonagh, CPA, currently serves as the Senior Manager of SEC Reporting & Technical Accounting at Esperion, a role held since January 2022. Prior positions include US Manufacturing Finance Manager at First Solar and Senior Associate at PwC, where Erin worked from August 2016 to September 2021, with a previous role as a Core Assurance Intern at PwC in 2015. Erin began their professional journey as a Finance Intern at Dana Holding Corporation and held a Teaching Assistant position at the University of Notre Dame, where responsibilities included administering IT Management assignments. Erin holds a Bachelor of Business Administration in Accounting and English from the University of Notre Dame and graduated from Bryan High School in 2012. Additionally, Erin gained early leadership experience as an Assistant Manager at Bryan Parks & Recreation.
This person is not in any offices
Esperion Therapeutics
2 followers
Through scientific and clinical excellence, and a deep understanding of cholesterol biology, the experienced Lipid Management Team at ESPERION is committed to developing new LDL-C lowering medicines that will make a substantial impact on reducing global cardiovascular disease, the leading cause of death around the world.